The Highly Expressed and Inducible Endogenous NAD(P)H:quinone Oxidoreductase 1 in Cardiovascular Cells Acts as a Potential Superoxide Scavenger

Author：  

Publisher： Humana Press, Inc

ISSN： 1530-7905

Source： Cardiovascular Toxicology, Vol.7, Iss.3, 2007-09, pp. : 202-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAD(P)H Oxidases and Their Relevance to Atherosclerosis

By Sorescu D.   Szocs K.   Griendling K.K.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 3, 2001-04 ,pp. : 124-131

Elsevier

Access to resources Recommend Favorite

NAD(P)H oxidase in the failing human heart

By Krijnen P.A.J.   Meischl C.   Visser C.A.   Hack C.E.   Niessen H.W.M.   Roos D.  

Journal of the American College of Cardiology, Vol. 42, Iss. 12, 2003-12 ,pp. : 2170-2171

Elsevier

Access to resources Recommend Favorite

The NAD(P)H Oxidase Inhibitor Apocynin Improves Endothelial NO/Superoxide Balance and Lowers Effectively Blood Pressure in Spontaneously Hypertensive Rats: Comparison to Calcium Channel Blockade

By Baumer Anselm T.   Kruger Christian A.   Falkenberg Juliane   Freyhaus Henrik Ten   Rosen Renate   Fink Klaus   Rosenkranz Stephan  

Clinical and Experimental Hypertension, Vol. 29, Iss. 5, 2007-06 ,pp. : 287-299

Informa Healthcare

Access to resources Recommend Favorite

THE CHEMOKINE CXCL16 IS HIGHLY AND CONSTITUTIVELY EXPRESSED BY HUMAN BRONCHIAL EPITHELIAL CELLS

By Day Caroline   Patel Rashmika   Guillen Cristina   Wardlaw Andrew  

Experimental Lung Research, Vol. 35, Iss. 4, 2009-05 ,pp. : 272-283

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases

By  

Current Vascular Pharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 59-65

Bentham Science Publishers

Access to resources Recommend Favorite